The stock of Illumina Inc (ILMN) has seen a -6.26% decrease in the past week, with a -30.28% drop in the past month, and a -30.40% decrease in the past quarter. The volatility ratio for the week is 5.41%, and the volatility levels for the past 30 days are at 4.22% for ILMN. The simple moving average for the past 20 days is -17.71% for ILMN’s stock, with a -25.66% simple moving average for the past 200 days.
Is It Worth Investing in Illumina Inc (NASDAQ: ILMN) Right Now?
Moreover, the 36-month beta value for ILMN is 1.15. Analysts have varying opinions on the stock, with 10 analysts rating it as a “buy,” 5 as “overweight,” 12 as “hold,” and 0 as “sell.”
The public float for ILMN is 157.62M and currently, short sellers hold a 4.13% of that float. On February 25, 2025, ILMN’s average trading volume was 2.35M shares.
ILMN) stock’s latest price update
Illumina Inc (NASDAQ: ILMN)’s stock price has plunge by -0.25relation to previous closing price of 94.20. Nevertheless, the company has seen a -6.26% plunge in its stock price over the last five trading sessions. zacks.com reported 2025-02-24 that Illumina Collaborates with Broad Clinical Labs to set the standard for scalable single-cell research and accelerate discovery in areas such as disease modeling and drug development.
Analysts’ Opinion of ILMN
Many brokerage firms have already submitted their reports for ILMN stocks, with Barclays repeating the rating for ILMN by listing it as a “Underweight.” The predicted price for ILMN in the upcoming period, according to Barclays is $100 based on the research report published on February 10, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see ILMN reach a price target of $140, previously predicting the price at $177. The rating they have provided for ILMN stocks is “Hold” according to the report published on February 07th, 2025.
Citigroup gave a rating of “Neutral” to ILMN, setting the target price at $165 in the report published on December 11th of the previous year.
ILMN Trading at -26.98% from the 50-Day Moving Average
After a stumble in the market that brought ILMN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.02% of loss for the given period.
Volatility was left at 4.22%, however, over the last 30 days, the volatility rate increased by 5.41%, as shares sank -31.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -36.31% lower at present.
During the last 5 trading sessions, ILMN fell by -6.26%, which changed the moving average for the period of 200-days by -21.03% in comparison to the 20-day moving average, which settled at $114.18. In addition, Illumina Inc saw -29.69% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ILMN starting from JAKOB WEDEL, who proposed sale 460 shares at the price of $100.00 back on Feb 18 ’25. After this action, JAKOB WEDEL now owns shares of Illumina Inc, valued at $46,000 using the latest closing price.
PATRICIA L LECKMAN, the Officer of Illumina Inc, proposed sale 1,756 shares at $100.00 during a trade that took place back on Feb 18 ’25, which means that PATRICIA L LECKMAN is holding shares at $175,600 based on the most recent closing price.
Stock Fundamentals for ILMN
Current profitability levels for the company are sitting at:
- 0.31 for the present operating margin
- 0.65 for the gross margin
The net margin for Illumina Inc stands at -0.28. The total capital return value is set at 0.28. Equity return is now at value -30.11, with -14.89 for asset returns.
Based on Illumina Inc (ILMN), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.33. The debt to equity ratio resting at 0.94. The interest coverage ratio of the stock is 13.55.
Currently, EBITDA for the company is -725.0 million with net debt to EBITDA at -1.95. When we switch over and look at the enterprise to sales, we see a ratio of 3.73. The receivables turnover for the company is 5.95for trailing twelve months and the total asset turnover is 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.78.
Conclusion
To wrap up, the performance of Illumina Inc (ILMN) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
